BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25963774)

  • 1. MicroRNA-122 associates with serum apolipoprotein B but not liver fibrosis markers in CHC genotype 1 infection.
    Lee TH; Matta B; King BD; Hodges MR; Tillmann HL; Patel K
    J Med Virol; 2015 Oct; 87(10):1722-6. PubMed ID: 25963774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection.
    Bihrer V; Friedrich-Rust M; Kronenberger B; Forestier N; Haupenthal J; Shi Y; Peveling-Oberhag J; Radeke HH; Sarrazin C; Herrmann E; Zeuzem S; Waidmann O; Piiper A
    Am J Gastroenterol; 2011 Sep; 106(9):1663-9. PubMed ID: 21606975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of biochemical markers and HCV RNA titers with fibrosis stages and grades in chronic HCV-3a patients.
    Shahid M; Idrees M; Nasir B; Raja AJ; Raza SM; Amin I; Rasul A; Tayyab GU
    Eur J Gastroenterol Hepatol; 2014 Jul; 26(7):788-94. PubMed ID: 24781355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of genetic polymorphism -670A>G in the Fas gene and serum markers AST platelet ratio index, AST/ALT with significant fibrosis and cirrhosis in chronic hepatitis C.
    Deghady A; Abdou A; El-Neanaey WA; Diab I
    Genet Test Mol Biomarkers; 2012 Jun; 16(6):531-5. PubMed ID: 22352690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C.
    Hsieh MY; Dai CY; Lee LP; Huang JF; Tsai WC; Hou NJ; Lin ZY; Chen SC; Wang LY; Chang WY; Chuang WL; Yu ML
    J Clin Pathol; 2008 Mar; 61(3):333-7. PubMed ID: 17545561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating microRNAs as predictive biomarkers for liver disease progression of chronic hepatitis C (genotype-4) Egyptian patients.
    El-Hefny M; Fouad S; Hussein T; Abdel-Hameed R; Effat H; Mohamed H; Abdel Wahab AH
    J Med Virol; 2019 Jan; 91(1):93-101. PubMed ID: 30133717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated miR-33a and miR-224 in steatotic chronic hepatitis C liver biopsies.
    Lendvai G; Jármay K; Karácsony G; Halász T; Kovalszky I; Baghy K; Wittmann T; Schaff Z; Kiss A
    World J Gastroenterol; 2014 Nov; 20(41):15343-50. PubMed ID: 25386083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased hepatic expression of miRNA-122 in patients infected with HCV genotype 3.
    Oliveira KG; Malta FM; Nastri AC; Widman A; Faria PL; Santana RA; Alves VA; Carrilho FJ; Pinho JR
    Med Microbiol Immunol; 2016 Apr; 205(2):111-7. PubMed ID: 26272127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum microRNAs as predictors for liver fibrosis staging in hepatitis C virus-associated chronic liver disease patients.
    Shaker OG; Senousy MA
    J Viral Hepat; 2017 Aug; 24(8):636-644. PubMed ID: 28211229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E-epsilon 4 protects against severe liver disease caused by hepatitis C virus.
    Wozniak MA; Itzhaki RF; Faragher EB; James MW; Ryder SD; Irving WL;
    Hepatology; 2002 Aug; 36(2):456-63. PubMed ID: 12143056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection.
    Hsu CS; Liu CH; Liu CJ; Hsu SJ; Chen CL; Hwang JJ; Lai MY; Chen PJ; Chen DS; Kao JH
    J Gastroenterol Hepatol; 2010 May; 25(5):970-7. PubMed ID: 20546452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis.
    Trebicka J; Anadol E; Elfimova N; Strack I; Roggendorf M; Viazov S; Wedemeyer I; Drebber U; Rockstroh J; Sauerbruch T; Dienes HP; Odenthal M
    J Hepatol; 2013 Feb; 58(2):234-9. PubMed ID: 23085648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PAPAS index: a novel index for the prediction of hepatitis C-related fibrosis.
    Ozel BD; Poyrazoğlu OK; Karaman A; Karaman H; Altinkaya E; Sevinç E; Zararsiz G
    Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):895-900. PubMed ID: 25951491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating microRNA-196a as a candidate diagnostic biomarker for chronic hepatitis C.
    Liu B; Xiang Y; Zhang HS
    Mol Med Rep; 2015 Jul; 12(1):105-10. PubMed ID: 25738504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of miR-122 level in the plasma of chronically HCV infected patients].
    Gholami M; Ravanshad M; Alavian SM; Baesi K; Moallemi S
    Mol Biol (Mosk); 2016; 50(2):279-83. PubMed ID: 27239848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-based diagnostic tools for advanced fibrosis and cirrhosis in patients with chronic hepatitis B and C.
    Appourchaux K; Dokmak S; Resche-Rigon M; Treton X; Lapalus M; Gattolliat CH; Porchet E; Martinot-Peignoux M; Boyer N; Vidaud M; Bedossa P; Marcellin P; Bièche I; Estrabaud E; Asselah T
    Sci Rep; 2016 Oct; 6():34935. PubMed ID: 27731343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma.
    Bihrer V; Waidmann O; Friedrich-Rust M; Forestier N; Susser S; Haupenthal J; Welker M; Shi Y; Peveling-Oberhag J; Polta A; von Wagner M; Radeke HH; Sarrazin C; Trojan J; Zeuzem S; Kronenberger B; Piiper A
    PLoS One; 2011; 6(10):e26971. PubMed ID: 22066022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parallel expression profiling of hepatic and serum microRNA-122 associated with clinical features and treatment responses in chronic hepatitis C patients.
    Butt AM; Raja AJ; Siddique S; Khan JS; Shahid M; Tayyab GU; Minhas Z; Umar M; Idrees M; Tong Y
    Sci Rep; 2016 Feb; 6():21510. PubMed ID: 26898400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive serum markers in the diagnosis of structural liver damage in chronic hepatitis C virus infection.
    Parise ER; Oliveira AC; Figueiredo-Mendes C; Lanzoni V; Martins J; Nader H; Ferraz ML
    Liver Int; 2006 Nov; 26(9):1095-9. PubMed ID: 17032410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.
    Petit JM; Benichou M; Duvillard L; Jooste V; Bour JB; Minello A; Verges B; Brun JM; Gambert P; Hillon P
    Am J Gastroenterol; 2003 May; 98(5):1150-4. PubMed ID: 12809841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.